| 发明名称 |
Chemical compounds |
| 摘要 |
The present invention provides a compound of a formula (I): wherein the variables are defined herein; to a process for preparing such a compound; and to the use of such a compound in the treatment of a chemokine (such as CCR3) or H1 mediated disease state. |
| 申请公布号 |
AU4699701(A) |
申请公布日期 |
2001.10.23 |
| 申请号 |
AU20010046997 |
申请日期 |
2001.04.05 |
| 申请人 |
ASTRAZENECA AB |
发明人 |
LOUISE LAWRENCE;AARON RIGBY;HITESH SANGANEE;BRIAN SPRINGTHORPE |
| 分类号 |
C07D295/20;A61K31/4375;A61K31/4545;A61K31/4709;A61K31/496;A61K31/498;A61K31/506;A61K31/519;A61K31/5377;A61K31/538;A61K31/5415;A61P1/00;A61P1/02;A61P1/04;A61P3/04;A61P3/10;A61P5/16;A61P7/06;A61P9/10;A61P11/00;A61P11/06;A61P11/08;A61P11/14;A61P17/00;A61P17/06;A61P17/14;A61P19/02;A61P19/08;A61P21/04;A61P25/00;A61P25/28;A61P27/02;A61P29/00;A61P31/08;A61P31/18;A61P37/00;A61P37/02;A61P37/06;A61P37/08;A61P43/00;C07D209/42;C07D211/46;C07D211/56;C07D211/58;C07D211/74;C07D279/16;C07D333/40;C07D401/04;C07D401/14;C07D405/14;C07D409/14;C07D413/12;C07D413/14;C07D417/06;C07D417/14;C07D471/04;C07D473/08;C07D487/04;C07D495/04;C07D513/04 |
主分类号 |
C07D295/20 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
